NI
70
2
UNM
70
2
JCI
44
2
DLTR
59
4
NEE
42
-2
SRE
45
-2
CLX
65
2
EOG
30
-2
FOXA
66
-3
SBUX
39
3
FDX
40
4
STI
12
-7
PLD
45
5
VFC
58
2
EW
57
2
ORLY
48
-4
WHR
59
-2
TXT
48
2
OI
30
5
KR
52
2
NI
70
2
UNM
70
2
JCI
44
2
DLTR
59
4
NEE
42
-2
SRE
45
-2
CLX
65
2
EOG
30
-2
FOXA
66
-3
SBUX
39
3
FDX
40
4
STI
12
-7
PLD
45
5
VFC
58
2
EW
57
2
ORLY
48
-4
WHR
59
-2
TXT
48
2
OI
30
5
KR
52
2
Financhill
Back

Universal Health Services Vs. Aligos Therapeutics Industry Stock Comparison

Buy
52

UHS
Universal Health Services

Last Price:
$181.13
Seasonality Move:
9.21%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$43.14
Seasonality Move:
-16.03%
Buy
52
Universal Health Services (UHS) is a Buy

Is Universal Health Services a Buy, Sell or Hold?

  • The current Universal Health Services [UHS] share price is $181.13. The Score for UHS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • UHS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UHS Stock Price Chart

What is Universal Health Services's stock price today?

  • The Universal Health Services share price today is $181.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UHS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

UHS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.55 Sell
Relative Strength Index (14 RSI): 32.81 Sell
Chaikin Money Flow: 126162 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (182.54 - 200.5) Sell
Bollinger Bands (100): (196.68 - 232.4) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

UHS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 180.41 Buy
20-day SMA: 189.48 Sell
50-day SMA: 201.93 Sell
200-day SMA: 197.58 Sell
8-day EMA: 181.93 Sell
20-day EMA: 187.78 Sell
50-day EMA: 198.24 Sell
200-day EMA: 195.17 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Universal Health Services Earnings Growth & UHS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.62 per share, and an increase next year of $2.24 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Universal Health Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):